Partner Jonathan Bachand was quoted in ‘When Can Biologic Patent Disputes Go Before the ITC?’ an article published by The Center for Biosimilars
Excerpt: The ITC has 2 remedies available to enforce Section 337 of the Tariff Act: an exclusion order to prevent the importation of articles into the United States, and a cease-and-desist order directed to US companies to prevent sales of items that are already in the country.
